BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 20569810)

  • 21. Innate cellular immune responses in newborns.
    Maródi L
    Clin Immunol; 2006; 118(2-3):137-44. PubMed ID: 16377252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the neonatal immune system: high risk for infection.
    McKenney WM
    Crit Care Nurse; 2001 Dec; 21(6):35-47. PubMed ID: 11767763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists.
    Levy O
    J Endotoxin Res; 2005; 11(2):113-6. PubMed ID: 15949138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of host defense peptides of the innate immune response in sepsis.
    Hirsch T; Metzig M; Niederbichler A; Steinau HU; Eriksson E; Steinstraesser L
    Shock; 2008 Aug; 30(2):117-26. PubMed ID: 18091568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prime time for trained immunity: innate immune memory in newborns and infants.
    Levy O; Wynn JL
    Neonatology; 2014; 105(2):136-41. PubMed ID: 24356292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early life response to infection.
    Ghazal P; Dickinson P; Smith CL
    Curr Opin Infect Dis; 2013 Jun; 26(3):213-8. PubMed ID: 23449137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease.
    Harbeson D; Ben-Othman R; Amenyogbe N; Kollmann TR
    Front Immunol; 2018; 9():1077. PubMed ID: 29896192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunction of innate immunity and associated pathology in neonates.
    Petrova A; Mehta R
    Indian J Pediatr; 2007 Feb; 74(2):185-91. PubMed ID: 17337832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Innate immunity, Toll receptor and sepsis].
    Carrillo-Esper R
    Cir Cir; 2003; 71(3):252-8. PubMed ID: 14617415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury.
    Kumar V
    Front Immunol; 2020; 11():1722. PubMed ID: 32849610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial defenses in the neonate.
    Quie PG
    Semin Perinatol; 1990 Aug; 14(4 Suppl 1):2-9. PubMed ID: 2237467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelets and Intravascular Immunity: Guardians of the Vascular Space During Bloodstream Infections and Sepsis.
    McDonald B; Dunbar M
    Front Immunol; 2019; 10():2400. PubMed ID: 31681291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using innate immunity to characterize the host response to microbial invasion in severe sepsis.
    Warner EA; Moldawer LL
    Future Microbiol; 2008 Apr; 3(2):177-89. PubMed ID: 18366338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes and clinical significance of Toll-like receptor 2 and 4 expression in neonatal infections].
    Zhang JP; Chen C; Yang Y
    Zhonghua Er Ke Za Zhi; 2007 Feb; 45(2):130-3. PubMed ID: 17456342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of S. epidermidis-induced innate immune responses in neonatal whole blood.
    Tröger B; Heidemann M; Osthues I; Knaack D; Göpel W; Herting E; Knobloch JK; Härtel C
    J Microbiol Immunol Infect; 2020 Apr; 53(2):240-249. PubMed ID: 30146415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity and toll-like receptors: clinical implications of basic science research.
    Abreu MT; Arditi M
    J Pediatr; 2004 Apr; 144(4):421-9. PubMed ID: 15069387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.
    Roger T; Schneider A; Weier M; Sweep FC; Le Roy D; Bernhagen J; Calandra T; Giannoni E
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E997-1005. PubMed ID: 26858459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.
    Calandra T; Froidevaux C; Martin C; Roger T
    J Infect Dis; 2003 Jun; 187 Suppl 2():S385-90. PubMed ID: 12792855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel therapeutic strategies based on toll-like receptor signaling.
    Lawton JA; Ghosh P
    Curr Opin Chem Biol; 2003 Aug; 7(4):446-51. PubMed ID: 12941417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications.
    Wu DD; Li T; Ji XY
    J Immunol Res; 2017; 2017():3591248. PubMed ID: 29075648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.